Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 14,460 shares at $9.63 ($139K) on 2023-12-05, disclosed to the SEC on 2023-12-06.
Seasonal sale ($139k) by President and CEO — this insider has traded ENTA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.63 | 7,230 | $70K | 50.0% |
| 2 | $9.63 | 7,230 | $70K | 50.0% |
| Total | $9.63 avg | 14,460 | $139K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |
| ENTA | SELL | 2022-12-16 | $2.3M | — | Filing → |